182 related articles for article (PubMed ID: 9497385)
1. Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue.
Lee GW; Melchior F; Matunis MJ; Mahajan R; Tian Q; Anderson P
J Biol Chem; 1998 Mar; 273(11):6503-7. PubMed ID: 9497385
[TBL] [Abstract][Full Text] [Related]
2. Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2.
Saitoh H; Sparrow DB; Shiomi T; Pu RT; Nishimoto T; Mohun TJ; Dasso M
Curr Biol; 1998 Jan; 8(2):121-4. PubMed ID: 9427648
[TBL] [Abstract][Full Text] [Related]
3. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1.
Bernier-Villamor V; Sampson DA; Matunis MJ; Lima CD
Cell; 2002 Feb; 108(3):345-56. PubMed ID: 11853669
[TBL] [Abstract][Full Text] [Related]
5. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
Reverter D; Lima CD
Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
[TBL] [Abstract][Full Text] [Related]
6. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex.
Matunis MJ; Wu J; Blobel G
J Cell Biol; 1998 Feb; 140(3):499-509. PubMed ID: 9456312
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme.
Schwarz SE; Matuschewski K; Liakopoulos D; Scheffner M; Jentsch S
Proc Natl Acad Sci U S A; 1998 Jan; 95(2):560-4. PubMed ID: 9435231
[TBL] [Abstract][Full Text] [Related]
8. Ubch9 conjugates SUMO but not ubiquitin.
Desterro JM; Thomson J; Hay RT
FEBS Lett; 1997 Nov; 417(3):297-300. PubMed ID: 9409737
[TBL] [Abstract][Full Text] [Related]
9. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2.
Okuma T; Honda R; Ichikawa G; Tsumagari N; Yasuda H
Biochem Biophys Res Commun; 1999 Jan; 254(3):693-8. PubMed ID: 9920803
[TBL] [Abstract][Full Text] [Related]
10. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex.
Matunis MJ; Coutavas E; Blobel G
J Cell Biol; 1996 Dec; 135(6 Pt 1):1457-70. PubMed ID: 8978815
[TBL] [Abstract][Full Text] [Related]
11. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
Karaca E; Tozluoğlu M; Nussinov R; Haliloğlu T
J Mol Biol; 2011 Mar; 406(4):620-30. PubMed ID: 21216249
[TBL] [Abstract][Full Text] [Related]
12. RanBP2 associates with Ubc9p and a modified form of RanGAP1.
Saitoh H; Pu R; Cavenagh M; Dasso M
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3736-41. PubMed ID: 9108047
[TBL] [Abstract][Full Text] [Related]
13. Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9.
Gong L; Kamitani T; Fujise K; Caskey LS; Yeh ET
J Biol Chem; 1997 Nov; 272(45):28198-201. PubMed ID: 9353268
[TBL] [Abstract][Full Text] [Related]
14. SUMO modification through rapamycin-mediated heterodimerization reveals a dual role for Ubc9 in targeting RanGAP1 to nuclear pore complexes.
Zhu S; Zhang H; Matunis MJ
Exp Cell Res; 2006 Apr; 312(7):1042-9. PubMed ID: 16469311
[TBL] [Abstract][Full Text] [Related]
15. Identification of a substrate recognition site on Ubc9.
Lin D; Tatham MH; Yu B; Kim S; Hay RT; Chen Y
J Biol Chem; 2002 Jun; 277(24):21740-8. PubMed ID: 11877416
[TBL] [Abstract][Full Text] [Related]
16. The binding interface between an E2 (UBC9) and a ubiquitin homologue (UBL1).
Liu Q; Jin C; Liao X; Shen Z; Chen DJ; Chen Y
J Biol Chem; 1999 Jun; 274(24):16979-87. PubMed ID: 10358047
[TBL] [Abstract][Full Text] [Related]
17. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1.
Desterro JM; Rodriguez MS; Kemp GD; Hay RT
J Biol Chem; 1999 Apr; 274(15):10618-24. PubMed ID: 10187858
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association.
Mahajan R; Gerace L; Melchior F
J Cell Biol; 1998 Jan; 140(2):259-70. PubMed ID: 9442102
[TBL] [Abstract][Full Text] [Related]
19. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification.
Sampson DA; Wang M; Matunis MJ
J Biol Chem; 2001 Jun; 276(24):21664-9. PubMed ID: 11259410
[TBL] [Abstract][Full Text] [Related]
20. Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.
Zhang H; Saitoh H; Matunis MJ
Mol Cell Biol; 2002 Sep; 22(18):6498-508. PubMed ID: 12192048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
